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ABSTRACT
The adult human heart possesses a limited regenerative potential
following an ischemic event, and undergoes a number of pathological
changes in response to injury. Although cardiac regeneration has
been documented in zebrafish and neonatal mouse hearts, it is
currently unknown whether the immature human heart is capable of
undergoing complete regeneration. Combined progress in pluripotent
stem cell differentiation and tissue engineering has facilitated the
development of human cardiac organoids (hCOs), which resemble
fetal heart tissue and can be used to address this important
knowledge gap. This study aimed to characterize the regenerative
capacity of immature human heart tissue in response to injury.
Following cryoinjury with a dry ice probe, hCOs exhibited an
endogenous regenerative response with full functional recovery 2
weeks after acute injury. Cardiac functional recovery occurred in the
absence of pathological fibrosis or cardiomyocyte hypertrophy.
Consistent with regenerative organisms and neonatal human
hearts, there was a high basal level of cardiomyocyte proliferation,
which may be responsible for the regenerative capacity of the hCOs.
This study suggests that immature human heart tissue has an intrinsic
capacity to regenerate.
KEY WORDS: Cardiac organoids, Cardiac tissue engineering,
Injury model, Regeneration
INTRODUCTION
In contrast to the mammalian heart, lower vertebrates such as
axolotls, newts and zebrafish are able to completely regenerate
damaged myocardium following cardiac injury in adult life
(Porrello and Olson, 2014). These regenerative animals initially
deposit extracellular matrix (ECM) proteins, similar to the response
of the mammalian heart following injury; but, in contrast, the scar
tissue is degraded and replaced by proliferating cardiomyocytes
(Chablais et al., 2011; Mercer et al., 2013; Poss et al., 2002).
Recently, this regenerative capacity has been shown to exist in a
mammalian system. It has been shown that newborn rodent hearts
possess an endogenous regenerative capacity following multiple
forms of injury, such as ventricular resection (Porrello et al., 2011;
Mahmoud et al., 2014), cryoinjury (Jesty et al., 2012; Darehzereshki
et al., 2015), coronary artery ligation (Haubner et al., 2012; Porrello
et al., 2013; Mahmoud et al., 2014) and genetic cardiomyocyte
ablation (Lavine et al., 2014). As observed in regenerating lower
vertebrates, the replacement of lost cardiomyocytes in newborn
rodents is dependent upon endogenous cardiomyocyte proliferation
(Porrello et al., 2011, 2013). This regenerative and proliferative
capacity rapidly diminishes during the first 7 days after birth in mice
(Porrello et al., 2011), suggesting that the cardiac regenerative
capacity is developmentally regulated in mammals. It is currently
unknownwhether a similar regenerativewindow exists in the human
heart, as there is no viable model system to study this process.
The possibility of cardiac regeneration in human children and
infants was first described almost a century ago following the
identification of split myocardial fibers in children infected with
diphtheria (Macmahon, 1937; Warthin, 1924). These early studies
support the concept of a regenerative window during human heart
development. Furthermore, recent case studies have emerged
documenting complete functional recovery of newborn human
hearts following myocardial infarction (MI) (Haubner et al., 2016;
Boulton et al., 1991). Haubner and colleagues made the striking
observation of complete functional recovery of a newborn human
heart following a severe myocardial infarction caused by coronary
artery occlusion (Haubner et al., 2016). Remarkably, the child was
able to completely recover cardiac function within weeks of the
initial ischemic insult, which translated into long-term restoration of
cardiac function. However, the authors were unable to determine
whether this phenomenon represented a true regenerative process or
whether it was due to stunning or to hibernation of the myocardium
following reperfusion. Thus, there is an unmet need to develop a
human model for assessing the intrinsic regenerative potential of
immature human heart tissue.
Recent advances in stem cell biology and tissue engineering
have provided unprecedented access to human heart tissue for
basic biological studies, disease modeling, drug screening and
regenerative medicine applications (Eder et al., 2016; Eschenhagen
et al., 2012). Robust protocols have been developed to differentiate
human pluripotent stem cells (hPSC), such as embryonic stem cells
(ESCs) and induced pluripotent stem cells (iPSCs), to produce
cardiomyocytes (Hudson and Zimmermann, 2011). In addition,
tissue-engineering approaches have been applied to stem cell-derived
cardiomyocytes to enhance their physiological relevance by
recapitulating the native 3D environment (Zhang et al., 2013).
Enhanced maturation and functionality of hPSC-CM can be achieved
by culturing in mechanically loaded engineered heart tissues (Yang
et al., 2014). Mechanical loading is used in these cultures as it
improves sarcomere length, organization of contractile proteins and
functionality (Tulloch et al., 2011; Fink et al., 2000). 3D-engineered
human cardiac organoids (hCOs) therefore provide a functionalmodel
with which to study human cardiac biology and regenerative
phenomena using experimental manipulations that are not feasibleReceived 22 August 2016; Accepted 17 January 2017
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in vivo. This study for the first time characterizes the injury response of
hCOs following cryoinjury in vitro. We report that hCOs resemble
fetal/neonatal-like human cardiac tissue and undergo functional
recovery, in the absence of fibrosis or hypertrophy, following injury.
These findings suggest that regenerative capacity is an intrinsic
property of immature human heart tissue.
RESULTS
hCOs possess features of immature human myocardium
Flow cytometry was used to characterize the major cell types derived
from a protocol based on a previously described 2D cardiac
differentiation protocol (Fig. 1A) (Hudson et al., 2012). At day 15
of differentiation, cultures were stained with markers (for validation,
see Fig. S1) for cardiomyocytes (α-actinin and cardiac troponin T),
stromal cells (CD90), endothelial cells (CD31) and leukocytes (CD45
and CD14), which are the major cell types present in the myocardium
in vivo (Pinto et al., 2016; Bergmann et al., 2009; Zhou and Pu,
2016). Flow analysis revealed that the majority of the total cell
population was positive for cardiomyocyte markers, with ∼60-70%
of cells expressing cTnT or α-actinin (Fig. 1B). The majority of the
non-myocyte population comprised CD90+ stromal cells, with 14
±3% CD90+ cells present at day 15 of differentiation in the
HES3 ESC line and a slightly higher proportion of CD90+ cells
(35±3%) present in the H9 ESC line (Fig. 1B). These ratios of
cardiomyocytes to CD90+ stromal cells are comparable with those
seen in the embryonic or neonatal rodent heart (Ieda et al., 2009).
Fewer than 1% of cells were positive for CD45/CD14 and CD31
markers in both cell lines, indicating that leukocytes and endothelial
cells are largely absent from this in vitro culture system.
To highlight the relative immaturity of hESC-derived cells
compared with adult cardiac cells, gene expression profiling of key
sarcomeric proteins, which change during cardiac maturation, were
analyzed and compared with native adult human whole heart
(Fig. 1C). β-Myosin heavy chain (β-MHC, also known as MYH7),
myosin light chain 2v (MLC2v also known as MYL2) and the N2B
isoform of titin (TTN N2B) (Opitz et al., 2004) are the dominant
isoforms expressed in adult cardiomyocytes. By contrast, alpha-
myosin heavy chain (α-MHC also known as MYH6), myosin light
chain 2a (MLC2a also known as MYL7, and the N2BA isoform of
titin (TTN N2BA) are the dominant isoforms expressed during early
embryonic development and in standard 2D cultures of hPSC-derived
cardiomyocytes (Veerman et al., 2015). qPCR analysis revealed that
hCOs had much lower expression of the adult sarcomeric isoforms
(β-MHC, MLC2v and TTN N2B) and higher expression of the fetal
sarcomeric isoforms (MLC2a), compared with native adult human
heart tissue (Fig. 1C). These findings indicate that hCOs display an
immature phenotype, as previously described for hPSC-derived
cardiomyocytes (Synnergren et al., 2012).
Using differentiated cardiac cells derived from H9, HES3 and
HES3NKX2-5eGFP/w cell lines, hCOswere formed using previously
described bioengineering approaches (Zimmermann et al., 2002;
Tiburcy et al., 2014; Soong et al., 2012). Briefly, cardiac cells were
cast in circular wells (Fig. 1D) in collagen 1. After 5 days in culture,
the 3D circular tissues were placed around elastic posts to impose
mechanical loading on the tissues to promote cardiomyocyte
alignment and functionality (Fig. 1D). Immunohistochemistry was
used to characterize the morphology and distribution of cells present
in hCOs. Sarcomeric proteins, such as α-actinin, tropomyosin and
titin (Fig. 1E), showed cardiomyocyte striation throughout the hCOs,
which also expressed the cardiac-specific marker myosin light chain
2v (MLC2v) (Fig. 1E). Stromal cells surrounded cardiomyocytes
throughout hCOs, which are vital for maintaining tissue architecture
(Fig. 1E and data not shown). The endothelial marker CD31 was not
detected in our hCO constructs (Fig. 1E). Transmission electron
microscopy (TEM)of sectioned hCOs revealed fully formedZ-discs,
which, in combination with α-actinin staining, is indicative of highly
organized sarcomeres (Fig. 1E). Cardiomyocyte coupling was
evident in 3D tissues; however, β-catenin and pan-cadherin
localization was circumferential rather than polarized to the
cardiomyocyte ends, which is indicative of structurally immature
cardiomyocytes rather than an adult phenotype (Fig. 1E).
We next assessed the functionality of hCOs by analyzing
contractile force in response to changes in extracellular calcium.
Organ bath recordings showed that hCO increased their force of
contraction in response to increasing concentrations of extracellular
calcium (Fig. 1F). Increasing calcium concentration had a positive
inotropic effect in HES3 hCOs (Fig. 1F), which is a characteristic
physiological property of cardiac muscle.
Together, these data characterize the cellular composition, protein
and gene expression of the hCO constructs. This characterization
indicates that hCO constructs contain primarily cardiomyocytes and
stromal cells at a ratio that is comparable with the fetal/neonatal
heart, and form functional sarcomere units that display
physiological inotropic responses to calcium. Overall, the hCOs
resemble immature myocardium and provide a physiologically
relevant in vitro model of fetal/neonatal human heart muscle.
Cryoinjury induces cell death and tissue ablation in hCOs
In order to determine whether immature hCOs can regenerate
following injury, we established a cryoinjury model. The cryoinjury
model was chosen over hypoxia-reoxygenation models so that we
could cause cardiomyocyte death in a localized areawhilemaintaining
viable tissue remote to the injury zone. This more closely recapitulates
cardiac injury in cases where myocardial infarction causes death to a
particular region of the heart. Cryoinjury models have been used
extensively in the literature to study cardiac regeneration in lower
vertebrates and neonatal rodents, as the technique results in localized
cell death with viable surrounding tissue (Chablais and Jazwinska,
2012;RobeyandMurry, 2008;Ciulla et al., 2004;Darehzereshki et al.,
2015). Cryoinjury was induced in hCOs by application of a small dry-
ice probe that covered thewidth and one-third of the length of the hCO
(∼100 μm×250 μm). Application of a dry-ice probe was the preferred
method of cryoinjury compared with using a metallic cryoprobe, as
whenweattempted to use ametallicprobe it became stuck to the tissue.
We next evaluated the extent of tissue damage caused by our
cryoinjury protocol.Using acardiomyocyte-specific green fluorescent
protein (GFP) cell line, HES3 NKX2-5eGFP/w, hCOs were visualized
in real time (Fig. 2Aii, iii). Cryoinjury resulted in an isolated loss of
GFP expression in ∼15% of hCOs (Fig. 2Aiii), which did not
compromise overall tissue integrity (Fig. 2Ai). Localized cryoinjury
was also confirmed with immunohistochemistry, which revealed the
same pattern of localized loss of α-actinin and nuclear staining in
HES3 hCOs, which was absent in controls (Fig. 2B,C). Cryoinjury
was further validated using two independent cell death assays for
lactate dehydrogenase (LDH) and cardiac troponin I (cTnI) release,
which are both used clinically to detect suspected myocardial damage
(Thygesen et al., 2012; Skillen, 1984). Cryoinjury in HES3 andHES3
NKX2-5eGFP/w hCOs resulted in an approximately threefold increase
in LDH release into the media compared with uninjured controls
(Fig. 2D). cTnI levels were also evaluated as a cardiomyocyte-specific
readout of cell death 4 h following cryoinjury. Similarly, cryoinjury
caused an approximately threefold increase in cTnI levels inHES3and
HES3 NKX2-5eGFP/w hCOs (Fig. 2E). These findings confirm that
cryoinjury of hCO induces localized cardiomyocyte death.
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Lack of fibrotic or hypertrophic responses following
cryoinjury in hCOs
Fibrosis and hypertrophy are characteristic hallmarks of the adult
reparative response following MI in humans. Similarly, adult
mammals deploy a fibrotic and hypertrophic response following
cryoinjury (Yang et al., 2010, 2011). By contrast, the neonatal heart is
characterized by an absence of fibrosis and hypertrophy following
cardiac injury (Porrello et al., 2011, 2013). In order to determine
whether hCOs displayed adult- or neonatal-like responses to cardiac
injury, we quantifiedmarkers of fibrosis and hypertrophy in HES3 and
HES3 NKX2-5eGFP/w hCOs following cryoinjury. Trichrome staining
was initially performed to visualize the deposition of ECM proteins.
However, this analysis was confounded by the collagen 1 matrix that
was used to make hCO. We therefore analyzed ECM gene expression
Fig. 1. hCOs display properties of
immature human heart tissue.
(A) Timeline of the differentiation
protocol and hCO formation.
(B) Representative flow cytometry
analysis of the cell types present after
the cardiac differentiation protocol (day
15). The average percentage of cell
types after differentiation of H9 and
HES3 embryonic stem cells is shown.
(C) Gene expression analysis of key
cardiac markers compared with adult
human heart. (D) Representative
image of the PDMS molds and PDMS
poles for mechanical loading used to
form the hCOs. hCOs in culture
medium on exercisers and with dry-ice
probe. Scale bars: 1 mm. (E) High-
magnification confocal images of
hCOs, outlining cell-cell junctions (pan
cadherin and β-catenin) and
sarcomeric proteins (titin and
tropomyosin). High-magnification
confocal images of hCOs stained with
cardiac (MLC2v), stromal cell (CD90)
and endothelial cell markers (CD31).
Scale bars: 20 μm. High-magnification
transmission electron microscopy
(TEM) image of sectioned hCOs. Scale
bar: 0.5 μm. (i) Two Z-discs; double-
headed arrow indicates length of
sarcomere. (ii) Cell-cell junction
(arrow). (F) Effect of increasing calcium
concentration on HES3 hCO force of
contraction using an organ bath (n=3),
***P<0.001 versus 0.2 mM Ca2+
analyzed using ANOVA with Sidak’s
multiple comparison post-test.
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at 1, 3, 7, 10 and 14 days post-cryoinjury, as this time frame has been
characterized in other in vivo cryoinjurymodels (Gonzalez-Rosa et al.,
2011; Sun et al., 2000). In contrast to the adult response to cardiac
injury in vivo, cryoinjury did not cause a global upregulation of ECM
genes or integrins, including collagen type 1 (COL1A1), collagen type
3 (COL3A1), elastin (ELN), fibronectin (FN1), integrin alpha 1
(ITGA1) and laminin γ subunits (LAMC1) (Fig. S2A). At 14 days
post-cryoinjury, FN1, ELN and IGTA1 were upregulated. Therefore
we used an alternative method to confirm whether there was fibrosis
and analyzed protein expression with western blot analysis at the same
time point. Quantification of fibronectin protein expression revealed
that there was no increase following cryoinjury (Fig. S2B). These
results indicate that cryoinjury does not cause a collagenous fibrotic
response in immature hCOs.
To characterize hypertrophy in this model, we analyzed the
expression of several cardiac stress genes, including atrial natriuretic
peptide (ANP also known asNPPA) and skeletal actin (ACTA1). qPCR
analysis revealed that there was no significant upregulation of ANP at
1, 3, 7, 10 or 14 days post-cryoinjuryor ofACTA1 at 1, 3, 7 and 10 days
post-cryoinjury (Fig. S2C). There was an upregulation of ACTA1 at
14 days post-cryoinjury, whereas ANP was highly variable in both
uninjured and cryoinjury groups. To formally assess hypertrophy,
histological analysis of cardiomyocyte cell size was performed to
quantify the cross-sectional area of cardiomyocytes at 14 days post-
injury (Fig. S2Di). This robust analysis revealed that cryoinjury did not
cause an increase in cell size in HES3 NKX2-5eGFP/w hCOs at day 14
post-injury (Fig. S2Dii). Collectively, these data indicate that
cryoinjury does not induce hypertrophy in immature hCOs.
Fig. 2. Cryoinjury of hCOs results in
localized cell death and reduced contractile
function. (Ai) Live HES3 NKX2-5eGFP/w hCOs
on exercise poles in culture. (ii) GFP imaging of
cardiomyocytes in live uninjured control hCOs.
(iii) GFP imaging of cardiomyocytes in
cryoinjured hCOs; arrow indicates loss of
cardiomyocytes. Scale bars: 2 mm. (B) Whole-
mount immunofluorescent image of an
uninjured hCO stained with α-actinin and
Hoechst33342. (C) Whole-mount
immunofluorescent image of a cryoinjured hCO
3 days post-cryoinjury; arrow indicates site of
injury. Scale bars: 1 mm. (D) Lactate
dehydrogenase change in HES3 (n=33, over 9
experiments) and HES3 NKX2-5eGFP/w (n=18,
over 6 experiments) hCOs in response to
cryoinjury. ****P<0.0001, using Student’s t-test.
(E) Cardiac troponin I detected in HES3 and
HES3 NKX2-5eGFP/w hCO medium 4 h post-
cryoinjury (n=5, 3 experiments). *P<0.02;
***P<0.001, using Student’s t-test.
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hCOs have high basal rates of cardiomyocyte proliferation
before and after cryoinjury
In contrast to adults, neonatal rodents are able to regenerate following
cardiac injury, including non-transmural cryoinjury (Darehzereshki
et al., 2015). Cardiac regeneration in neonates is associated with high
basal rates of cardiomyocyte proliferation, which increases further
upon injury in somemodels (Porrello et al., 2013; Bryant et al., 2014).
As hCOs did not undergo fibrosis or hypertrophy following
cryoinjury, we examined whether cardiomyocyte cell cycle activity
was upregulated. Cardiomyocyte cell cycle activity was quantified by
immunohistochemical analysis of Ki-67+ (Fig. 3A,B) and
phosphorylated Histone H3 (pH3+) (Fig. 3D,E) cardiomyocytes at
3 days post-cryoinjury. A trend towards increased numbers of Ki-67+
cardiomyocytes (Fig. 3C) and a significant increase in pH3+
cardiomyocytes with disassembled sarcomeres (Fig. 3F) were
detected in HES3-derived hCOs following cryoinjury. However,
cryoinjury did not cause a significant increase in pH3+
cardiomyocytes in H9 or HES3 NKX2-5eGFP/w hCO (Fig. 3F),
suggesting that this proliferative response varies between cell lines.
Nevertheless, even in the absence of injury, cardiomyocyte
proliferation rates in hCO constructs were similar to neonatal
human heart tissue (Polizzotti et al., 2015), providing further
support for the notion that this model recapitulates immature
human myocardium. To confirm repopulation of the hCOs with
cardiomyocytes, we tracked GFP intensity of hCOs fabricated using
the cardiomyocyte-specific reporter line HES3 NKX2-5eGFP/w.
Fig. 3. Cryoinjury is associated with high basal rates of cardiomyocyte proliferation in hCOs. (A,B) High-magnification images of (A) control HES3 hCOs
and (B) cryoinjured HES3 hCOs stained with α-actinin, Ki-67 and Hoechst33342. (C) Quantification of Ki-67-positive cardiomyocytes in HES3 hCOs (n=12, four
experiments). (D,E) High-magnification images of (D) control HES3 hCOs and (E) cryoinjured HES3 hCOs stained with α-actinin, pH3 and Hoechst33342.
(F) Quantification of pH3-positive cardiomyocytes in HES3 hCOs (n=5-7), H9 HCOs (n=7-10) and HES3NKX2-5eGFP/w hCOs (n=5 or 6). *P<0.05, using Student’s
t-test. Scale bars: 50 μm. (G,H) GFP images created using HES3 NKX2-5eGFP/w-derived hCOs showing (G) uninjured hCOs and (H) cryoinjured hCOs at 0, 3 and
14 days post-cryoinjury live in culture. (I) GFP (cardiomyocyte) intensity at 0, 3 and 14 days post-cryoinjury (n=4). *P<0.05, using Student’s t-test.
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Consistent with cardiomyocyte death, we found that GFP intensity
was reduced 3 days post-cryoinjury (Fig. 3G,H). Inspection of HES3
NKX2-5eGFP/w tissues at day 14 indicated that the majority of the
injured region had regenerated and GFP intensity levels were
indistinguishable from control uninjured hCOs after 14 days (Fig. 3I).
hCOs regenerate and recover cardiac function following
cryoinjury
Owing to their immature physiological properties, high rates of
cardiomyocyte proliferation and lack of a fibrotic or hypertrophic
response to cryoinjury, we next tested whether hCOs regenerated
following cryoinjury. Contractile force was determined at multiple
time points (Fig. 4A) following cryoinjury using electrical pacing at
1 Hz with video analysis and a customized motion tracking
computer program (see Materials and Methods and Fig. S3). At
6 h following cryoinjury, there was a 53% and a 57% reduction in
active force in HES3 and HES3 NKX2-5eGFP/w hCOs, respectively
(Fig. 4B). Similarly, a trend towards active force reduction (65%,
P=0.07) was observed 6 h after cryoinjury in H9 hCOs but this
failed to reach statistical significance (Fig. 4B). Remarkably, active
force recovered 14 days post-cryoinjury, measured using electrical
pacing at 1 Hz with video analysis and a customized motion
tracking computer program (Fig. 4C). We also used organ bath
experiments to measure active force at 14 days post-cryoinjury. This
analysis indicated that contractile forces had substantially recovered
in all three hCO lines towards hCO forces in the uninjured tissues
(Fig. 4C). These data suggest that immature hCOs are able to
functionally recover following cryoinjury.
Macrophages have been implicated in neonatal heart regeneration
where monocyte depletion impaired angiogenesis and abolished
the regenerative response to infarction (Aurora et al., 2014).
Importantly, neonatal monocyte depletion impaired angiogenesis
but did not affect cardiomyocyte proliferation in vivo. As our hCOs
do not require vascularization and endothelial cells are absent from
the hCOs, we tested whether the addition of monocytes from cord
blood or adult humans would impact fibrosis and cardiomyocyte
proliferation in hCOs. We validated monocyte survival at 3 days
post-cryoinjury with immunohistochemical staining and gene
expression analysis of the monocyte marker CD14 (Fig. S4A,B).
There was no significant change in Ki-67-positive cardiomyocytes
following cryoinjury with cord blood or adult CD14+ monocyte co-
culture (Fig. S4C). We also assessed gene expression of
extracellular matrix genes COL1A1, COL3A1, ELN, FN1, ITGA1
and LAMC1 at 3 days post-cryoinjury with co-culture of both cord
blood and adult human CD14+ monocytes (Fig. S4D). We found
that there was no significant upregulation of extracellular matrix
genes following cryoinjury at this time point with co-culture of
either monocyte population. Consistent with in vivo data, these
results indicate that monocytes do not regulate the proliferative
response of immature hCOs.
We next tested whether the recovery of the hCO functionality
after cryoinjury was due to cardiomyocyte proliferation. To test this
hypothesis, we inhibited cardiomyocyte proliferation with the
chemotherapeutic agent mitomycin C (Fig. 4E). Mitomycin C has
been shown to inhibit proliferation in a number of cell types in vitro
while the cells remain viable (Chen et al., 2013; Nieto et al., 2007).
We found no cardiomyocyte proliferation marked by pH3-positive
cardiomyocytes treatment with mitomycin C 6 h after cryoinjury
(n=3 hCOs, 1893 cells counted, Fig. 4F). We found that there was
no effect on force of contraction after 14 days with no injury
indicating that hCO viability and functionality was not effected by
mitomycin C treatment (Fig. 4G). However, mitomycin C prevented
functional recovery of force of contraction analyzed 14 days after
cryoinjury (Fig. 4G). This indicates that functional recovery
following cryoinjury requires proliferation.
DISCUSSION
A major limitation to studying human cardiac regeneration is the
lack of models and tissue samples to study the repair responses of
the human heart following injury. To date, a human model of acute
cardiac injury has not been achieved. Instead, most research into
regeneration following cardiac injury has relied on the use of animal
models. hCOs have been proposed as a physiologically relevant
model of the human heart (Caspi et al., 2007; Schaaf et al., 2011;
Tiburcy et al., 2011), which has a variety of applications from drug
screening to studying human cardiac biology. However, hCOs have
yet to be applied to meet the demand for an in vitro system to study
cardiac regenerative phenomena. To address this problem and
provide insight into the endogenous repair processes of the
immature human heart, we developed and characterized a human
in vitro model of acute cryoinjury. Importantly, our hCO constructs
were found to be physiologically representative of the native
immature human heart. This finding is consistent with the
characterization of other hCO constructs, which were also found
to be most comparable with the fetal human heart (Veerman et al.,
2015). Remarkably, hCOs were able to completely recover cardiac
function following cryoinjury, displaying many of the hallmarks of
regenerative neonatal heart tissue.
The major finding from this study is that immature human heart
tissue possesses an innate ability to regenerate following injury.
Interestingly, in our in vitro system, myocytes possess an
endogenous ability to recover contractile force following injury,
which occurs independently of other infiltrating/resident cell types
that are present within the in vivo setting. As the immune system has
been heavily associated with reparative responses following cardiac
injury in many animal systems (Nahrendorf et al., 2007; Evans et al.,
2013; Frantz and Nahrendorf, 2014; Aurora et al., 2014), an
interesting implication of our finding is that immune cells are not
required for functional recovery of immature heart tissue.
Furthermore, the addition of monocytes in our studies did not have
any impact on cardiomyocyte proliferation, which is consistent with
in vivo observations (Aurora et al., 2014). This suggests that
immature human heart muscle may possess an intrinsic ability to
mount a regenerative response, which occurs even in the absence of
inflammation and angiogenesis. However, it should be noted that our
in vitro model does not fully recapitulate the in vivo setting, which
could be important for studying the actions of the immune system of
the regenerative process. As macrophages predominantly influence
the angiogenic response to infarction in neonates (Aurora et al.,
2014), co-culture of hCOs with endothelial cells and immune cells
could provide another important avenue for future investigation.
In regenerating animals, damaged myocardium gets replaced by
proliferating cardiomyocytes (Poss et al., 2002; Porrello et al.,
2011). In our model, we found that cryoinjury only caused a
significant increase in myocyte proliferation in one out of three
human embryonic stem cell lines. However, hCOs from all three cell
lines, HES3, H9 and HES3 NKX2-5eGFP/w exhibited high levels of
cardiomyocyte proliferation under basal conditions. Interestingly,
the basal levels of proliferation in hCOs were higher than those
reported in regenerating zebrafish hearts (Sallin et al., 2015),
regenerating neonatal mouse hearts (Porrello et al., 2013) and
neonatal human hearts (Polizzotti et al., 2015). In these animals,
damaged myocardium is replaced within several weeks, which is
comparable with the timeframe over which we detected force
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recovery. Our results with mitomycin C inhibition of the cell cycle
also indicate that proliferation was responsible for force recovery in
our cryoinjury model. In future, it will also be interesting to
determine whether more mature cell cycle arrested hCOs display
regenerative capacity or not, although this first requires knowledge
of the key processes that drive maturation (Yang et al., 2014).
In conclusion, this is the first study to characterize an injury
model in hCOs, which we propose to model human fetal hearts. We
demonstrate that immature hCO can functionally recover following
localized injury. Our study provides novel insight into the
endogenous regenerative capacity of the immature human heart,
which cannot be investigated in the in vivo setting. Our model is
Fig. 4. Functional recovery following
cryoinjury of hCOs. (A) Timeline of force
analysis following cryoinjury. (B) Change in
active force analyzed using tracking of elastic
posts and pacing at 1 Hz 6 h post-cryoinjury in
HES3 (n=14, three experiments), H9 (n=5)
and HES3 NKX2-5eGFP/w (n=4-6) hCOs.
**P<0.005 and *P<0.05, using Student’s t-test.
(C) Change in active force analyzed using
tracking of elastic posts and pacing at 1 Hz
14 days post-cryoinjury in HES3 (n=5-6) and
H9 (n=5) hCOs. (D) Active force of HES3
(n=14-16, at least four experiments), H9 (n=3
or 4) and HES3NKX2-5eGFP/w (n=4 or 5) hCOs
14 days post-cryoinjury measured using organ
baths. *P<0.05, using Student’s t-test.
(E) Timeline of mitomycin C treatment
protocol. (F) High-magnification image of
mitomycin C-treated HES3 hCOs stained with
α-actinin, pH3 and Hoechst33342.
(G) Analysis of active force generation using
tracking of elastic posts and pacing at 1 Hz
14 days post-cryoinjury in HES3 hCOs. Active
force comparison of non-injured hCOs [either
non-treated (data taken from C) andmitomycin
C treated (n=3-6)]. Active force comparison of
cryoinjured hCOs [either non-treated or
Mitomycin C treated (n=6 or 7)]. *P<0.05,
using Mann–Whitney test.
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consistent with aspects of neonatal heart regeneration observed
in vivo: lack of fibrosis, lack of hypertrophy, high baseline
proliferation rates, and functional recovery after injury (Porrello
et al., 2011, 2013). Our model therefore provides a unique
opportunity to interrogate the molecular and cellular mechanisms
governing regeneration of immature human heart tissue.
MATERIALS AND METHODS
Human embryonic stem cell culture
Ethical approval for the use of human embryonic stem cells was obtained
from The University of Queensland’s Medical Research Ethics Committee
(2014000801), and was carried out in accordance with the National Health
and Medical Research Council of Australia (NHMRC) regulations. All
experimental protocols were approved by The University of Queensland’s
Medical Research Ethics Committee. The hESC lines HES3 and H9 were
obtained from WiCell, where informed consent was obtained from all
subjects. Additionally, we used the previously published HES3 NKX2-
5eGFP/w cardiac reporter line (Elliott et al., 2011). Human ESCs were
cultured on Matrigel (Corning)-coated flasks with mTeSR (Stem Cell
Technologies) supplemented with 0.5% penicillin-streptomycin (Thermo
Fisher Scientific). Cells were seeded at 20,000 cells/cm2 (HES3 and H9
lines) and 10,000 cells/cm2 (HES3 NKX2-5eGFP/w), passaging with TrypLE
(Thermo Fisher) every 3 or 4 days.
Cardiac differentiation protocol
Cardiomyocyte and stromal cell differentiation was achieved using
modification of previously described protocols (Hudson et al., 2012),
which are further described in the supplementary Materials and Methods.
At day 15 of differentiation, cells were harvested with 0.2% collagenase
type I (Sigma-Aldrich) in 20% FBS in PBS (with Ca2+ and Mg2+) for
60 min, followed by further digestion with 0.25% Trypsin-EDTA (Thermo
Fisher Scientific) for 10 min. Trypsin was neutralized with α-MEM
medium 10% FBS (supplemented with 1% penicillin-streptomycin,
200 mM L-ascorbic acid) and strained through a 100μm filter. The cells
were then resuspended at 4.6×106 cells/ml in α-MEM medium for hCO
formation.
Forming hCO constructs
hCO constructs were made using differentiated cardiac cells, cold 7.3 mg/ml
acid-solubilized bovine collagen 1 (Devro), 0.1 mol l−1 sodium hydroxide
in milliQ water and 10× Dulbecco’s Modified Eagle’s medium (DMEM)
(Thermo Fisher Scientific) at the ratios outlined in Table S1. Each circular
hCO mold (Sylgard 184, Dow Corning) was filled with 140 μl of cell
mixture and incubated at 37°C with 5% CO2 for 30 min to gel before α-
MEM medium 10% FBS was added. After 5 days in the mold, hCOs were
carefully removed and placed around silicon exercisers using sterile forceps.
α-MEM 10% FBS medium was replaced every 2 or 3 days and cryoinjury
was performed after 7 days of culture on the exercisers (total differentiation
culture of 27 days).
Flow cytometry
On day 15 of cardiac differentiation, cells were harvested as described above.
Differentiated cells were stained as described in the supplementary Materials
and Methods with the following primary antibodies: α-actinin (Sigma-
Aldrich, A7811, 1:1000), cardiac troponin T (Thermo Scientific, MS295P1,
1:400), CD90 (Thermo Fisher Scientific, MAB2067, 1:125), CD31
(eBioscience, 17-0319-42, 1:200), CD14 (Miltenyi Biotech, 130-091-243,
1:1) and CD45 (Miltenyi Biotech, 130-098-043, 1:10). These primary
antibodies were validated as shown in Fig. S1.
Cryoinjury protocol for hCOs
On day 27, cryoinjury was performed using a sterile piece of dry ice. Prior to
cryoinjury, culture medium was removed to allow precise contact between
the topmost arm of the hCOs and the dry ice for 3 s. Medium was
then replaced immediately following cryoinjury and incubated at 37°C in
5% CO2.
Lactate dehydrogenase assay and cardiac troponin I Elisa
Media samples were collected at 4 h post-cryoinjury. Cardiac Troponin I
Elisa kit (RayBio) and Lactate dehydrogenase (LDH) Assay (Pierce) were
used according to the manufacturer’s instructions. For LDH analysis, hCOs
were incubated in phenol-free medium (Table S2) following cryoinjury until
sample collection when they were returned to α-MEM 10% FBS medium.
Immunohistochemistry
hCO constructs were fixed with 1% paraformaldehyde (PFA) in PBS for 1 h
and stained at 4°C with shaking overnight with the following primary
antibodies: α-actinin (Sigma, A7811, 1:1000), Ki67 (Cell Signaling
Technologies, 9129S, 1:400), pH3 (Merck Millipore, 05-806, 1:200),
Pan-cadherin (Sigma, C3678, 1:200), beta-catenin (Cell Signaling
Technologies, 8480S, 1:200), Titin (Developmental Studies Hybridoma
Bank, 9D10, 5 μg/ml), MLC2V (Protein Tech Group, 10906-1-AP, 1:200)
and tropomyosin (Developmental Studies Hybridoma Bank, LC1, 5 μg/ml).
hCOs were incubated at 4°C with shaking overnight with the following
secondary antibodies: Alexa-fluor goat anti-rabbit 488 (Life Technologies,
A11034, 1:400), Alexa-fluor goat anti-mouse 555 (Life Technologies,
A21422, 1:400), Hoechst 33342 (Thermo Fisher Scientific, H3570,
1:1000). Images were obtained using Olympus FV1000 Inverted
Confocal microscope or Zeiss PALM Microbeam Laser System. For Ki67
and pH3 cardiomyocyte proliferation quantification, multiple images were
taken at random locations throughout the tissue and cardiomyocyte
proliferation quantification was performed blinded.
Histology
At 14 days post-cryoinjury, hCO constructs were fixed in 1% PFA in PBS
for 1 h before histological tissue processing. Transverse sections (6 μm)
were cut along the tissue long axis to obtain cardiomyocyte cross-sections
before staining with Wheat Germ Agglutinin (50 μg ml−1, Thermo Fisher
Scientific) and Hoechst33342 (1:1000). Cardiomyocyte cell size was
measured using ImageJ software and presented as a scatter plot.
Electron microscopy
Samples were also processed for electron microscopy as described previously
(Takasato et al., 2015). Sections were analyzed unstained using a Jeol1011
transmission electron microscope (Tokyo, Japan).
Quantitative RT-PCR
Adult human heart RNA from healthy adult humans was obtained from
Clontech. RNA was extracted from hCO constructs with Trizol (Thermo
Fischer Scientific), according to the manufacturer’s instructions and is
outlined in the supplementary Materials andMethods. Primer sequences are
also outlined in Table S3.
Mitomycin C treatment
hCOs were incubated in 10 μg ml−1 mitomycin C in α-MEM 10% FBS with
gentle agitation for 90 min in 5% CO2 at 37°C. hCOs were washed three
times in PBS and returned to α-MEM 10% FBS.
Western blotting
Cells were harvested in ice-cold Mammalian Protein Extraction Reagent
(Thermo Fisher Scientific) containing complete EDTA-free protease inhibitor
and phosphatase inhibitor cocktail tablets (Roche). Protein concentration was
determined using a Pierce BCA Protein Assay Kit (Thermo Fisher Scientific)
according to themanufacturer’s instructions. Protein samplesweremixedwith
Laemmli sample buffer containing 10% β-mercaptoethanol prior to boiling at
95°C for 5 min. Samples were resolved by SDS-PAGE and transferred onto
PVDFmembrane (Immobilon-P,MerckMillipore).Membraneswere blocked
with Odyssey blocking buffer (LI-COR Biosciences). Primary antibodies
(fibronectin, Abcam, ab2413; or GAPDH, Cell Signaling Technology,
2118S) were prepared in a 1:1 mix of PBS and Odyssey blocking buffer (LI-
COR Biosciences) with 1% Tween20. Membranes were treated with the
relevant secondary antibody in a 1:1mix of PBS and Odyssey blocking buffer
with 0.1% SDS. Care was taken not to expose secondary antibodies or
membranes to light prior to visualization of immunolabeled proteins using an
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Odyssey infrared imager (LI-COR Biosciences). Densitometry analysis of
membrane was performed using Image Studio Version 5.2 software and
fibronectin was normalized to GAPDH.
Force analysis and electrical stimulation of hCO
The active force of hCOs was measured using a Panlab organ bath system at
day 14 post-cryoinjury. hCOs were stimulated in Tyrode’s solution
containing 2 mM calcium under 2 Hz field stimulation, 10 ms rectangular
pulses and 200 mV electric current. Labchart Pro was used to record and
analyze contractile force. Force was calculated using the average cycle
height of contraction and represented as mean active force (mN)±s.e.m.
For calculation of active force from pole movement, a Leica DMi8
inverted high content imager was used to capture a 10 s video of hCOs at 6 h
or 14 days post-cryoinjury contracting in real time at 37°C. During
recording, hCOs were electrically stimulated in a tissue culture plate at
1 Hz, 10 ms rectangular pulses and ∼100 mV using a conductive wire to
transduce electrical current from the organ bath stimulator into the culture
medium. Force analysis is detailed in the supplementary Materials and
Methods.
Monocyte co-culture
Human cord blood and peripheral blood CD14+ monocytes were co-
cultured with HES3 hCOs immediately following cryoinjury in custom well
inserts. Subsequently, the hCOs were cultured using our standard protocol.
For further details, see supplementary Materials and Methods.
Statistical analysis
Data are represented as mean±s.e.m. and statistical analysis was performed
using GraphPad Prism 6. Student’s t-test and two-way ANOVAwere used to
determine statistical significance, with P<0.05 considered significant.
Acknowledgements
We gratefully acknowledge the help of Charles Ferguson with EM processing and
the Australian Microscopy & Microanalysis Research Facility at the Center for
Microscopy and Microanalysis, the University of Queensland. We also
acknowledge the Developmental Biology HybridomaBank for providing the Titin and
tropomyosin antibodies, and Shannon O’Brien for assistance with western blotting
protocols.
Competing interests
The author(s) declare no competing financial interests. J.E.H is listed as an inventor
on patents WO 2015/025030 A1 and WO 2015/040142 Al related to cardiac
differentiation and hCO technologies described in this manuscript.
Author contributions
H.K.V., E.R.P. and J.E.H. conceived the experiments. J.E.H., R.J.M. and R.G.P.
conducted experiments and analyzed data. D.A.E. provided cell lines. H.K.V.
conducted experiments, analyzed data and wrote the manuscript. H.K.V., E.R.P.
and J.E.H. analyzed the results. J.E.H. and E.R.P. obtained funding to support the
experiments. All authors reviewed and edited the manuscript.
Funding
E.R.P. and J.E.H. are supported by grants and fellowships from the National Health
and Medical Research Council of Australia, the National Heart Foundation of
Australia, Stem Cells Australia and The University of Queensland. R.G.P. is
supported by the National Health and Medical Research Council of
Australia (program grant APP1037320 and Senior Principal Research Fellowship
569452) and by the Australian Research Council Centre of Excellence
(CE140100036).
Supplementary information
Supplementary information available online at
http://dev.biologists.org/lookup/doi/10.1242/dev.143966.supplemental
References
Aurora, A. B., Porrello, E. R., Tan, W., Mahmoud, A. I., Hill, J. A., Bassel-Duby,
R., Sadek, H. A. and Olson, E. N. (2014). Macrophages are required for neonatal
heart regeneration. J. Clin. Invest. 124, 1382-1392.
Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabé-Heider, F.,
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regenerates after cryoinjury-induced myocardial infarction. BMCDev. Biol. 11, 21.
Chen, N., Zhang, J., Xu, M., Wang, Y. L. and Pei, Y. H. (2013). Inhibitory effect of
mitomycin C on proliferation of primary cultured fibroblasts from human airway
granulation tissues. Respiration 85, 500-504.
Ciulla, M. M., Paliotti, R., Ferrero, S., Braidotti, P., Esposito, A., Gianelli, U.,
Busca, G., Cioffi, U., Bulfamante, G. and Magrini, F. (2004). Left ventricular
remodeling after experimental myocardial cryoinjury in rats. J. Surg. Res. 116,
91-97.
Darehzereshki, A., Rubin, N., Gamba, L., Kim, J., Fraser, J., Huang, Y., Billings,
J., Mohammadzadeh, R., Wood, J., Warburton, D. et al. (2015). Differential
regenerative capacity of neonatal mouse hearts after cryoinjury. Dev. Biol. 399,
91-99.
Eder, A., Vollert, I., Hansen, A. and Eschenhagen, T. (2016). Human engineered
heart tissue as a model system for drug testing. Adv. Drug Delivery. Rev. 96,
214-224.
Elliott, D. A., Braam, S. R., Koutsis, K., Ng, E. S., Jenny, R., Lagerqvist, E. L.,
Biben, C., Hatzistavrou, T., Hirst, C. E., Yu, Q. C. et al. (2011). NKX2-5(eGFP/w)
hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat.
Methods 8, 1037-1040.
Eschenhagen, T., Eder, A., Vollert, I. and Hansen, A. (2012). Physiological
aspects of cardiac tissue engineering. Am. J. Physiol. Heart Circ. Physiol. 303,
H133-H143.
Evans, M. A., Smart, N., Dube, K. N., Bollini, S., Clark, J. E., Evans, H. G., Taams,
L. S., Richardson, R., Levesque, M., Martin, P. et al. (2013). Thymosin beta4-
sulfoxide attenuates inflammatory cell infiltration and promotes cardiac wound
healing. Nat. Commun. 4, 2081.
Fink, C., Ergün, S., Kralisch, D., Remmers, U., Weil, J. and Eschenhagen, T.
(2000). Chronic stretch of engineered heart tissue induces hypertrophy and
functional improvement. FASEB J. 14, 669-679.
Frantz, S. and Nahrendorf, M. (2014). Cardiac macrophages and their role in
ischaemic heart disease. Cardiovasc. Res. 102, 240-248.
Gonzalez-Rosa, J. M., Martin, V., Peralta, M., Torres, M. andMercader, N. (2011).
Extensive scar formation and regression during heart regeneration after cryoinjury
in zebrafish. Development 138, 1663-1674.
Haubner, B. J., Adamowicz-Brice, M., Khadayate, S., Tiefenthaler, V., Metzler,
B., Aitman, T. and Penninger, J. M. (2012). Complete cardiac regeneration in a
mouse model of myocardial infarction. Aging 4, 966-977.
Haubner, B. J., Schneider, J., Schweigmann, U., Schuetz, T., Dichtl, W., Velik-
Salchner, C., Stein, J.-I. and Penninger, J. M. (2016). Functional recovery of a
human neonatal heart after severe myocardial infarction.Circ. Res. 118, 216-221.
Hudson, J. E. and Zimmermann, W.-H. (2011). Tuning Wnt-signaling to enhance
cardiomyogenesis in human embryonic and induced pluripotent stem cells. J. Mol.
Cell. Cardiol. 51, 277-279.
Hudson, J., Titmarsh, D., Hidalgo, A., Wolvetang, E. and Cooper-White, J.
(2012). Primitive cardiac cells from human embryonic stem cells. Stem Cells Dev.
21, 1513-1523.
Ieda, M., Tsuchihashi, T., Ivey, K. N., Ross, R. S., Hong, T.-T., Shaw, R. M. and
Srivastava, D. (2009). Cardiac fibroblasts regulate myocardial proliferation
through beta1 integrin signaling. Dev. Cell 16, 233-244.
Jesty, S. A., Steffey, M. A., Lee, F. K., Breitbach, M., Hesse, M., Reining, S., Lee,
J. C., Doran, R. M., Nikitin, A. Y., Fleischmann, B. K. et al. (2012). c-kit+
precursors support postinfarction myogenesis in the neonatal, but not adult, heart.
Proc. Natl Acad. Sci. USA 109, 13380-13385.
Lavine, K. J., Epelman, S., Uchida, K., Weber, K. J., Nichols, C. G., Schilling,
J. D., Ornitz, D. M., Randolph, G. J. and Mann, D. L. (2014). Distinct
macrophage lineages contribute to disparate patterns of cardiac recovery and
remodeling in the neonatal and adult heart. Proc. Natl. Acad. Sci. USA 111,
16029-16034.
Macmahon, H. E. (1937). Hyperplasia and regeneration of the myocardium in
infants and in children. Am. J. Pathol. 13, 845-854 5.
Mahmoud, A. I., Porrello, E. R., Kimura,W., Olson, E. N. and Sadek, H. A. (2014).
Surgical models for cardiac regeneration in neonatal mice. Nat. Protoc. 9,
305-311.
Mercer, S. E., Odelberg, S. J. and Simon, H.-G. (2013). A dynamic spatiotemporal
extracellular matrix facilitates epicardial-mediated vertebrate heart regeneration.
Dev. Biol. 382, 457-469.
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T.,
Figueiredo, J.-L., Libby, P., Weissleder, R. and Pittet, M. J. (2007). The healing
1126
STEM CELLS AND REGENERATION Development (2017) 144, 1118-1127 doi:10.1242/dev.143966
D
E
V
E
LO
P
M
E
N
T
myocardium sequentially mobilizes two monocyte subsets with divergent and
complementary functions. J. Exp. Med. 204, 3037-3047.
Nieto, A., Cabrera, C. M., Catalina, P., Cobo, F., Barnie, A., Cortes, J. L., Barroso
Del Jesus, A., Montes, R. and Concha, A. (2007). Effect of mitomycin-C on
human foreskin fibroblasts used as feeders in human embryonic stem cells:
immunocytochemistry MIB1 score and DNA ploidy and apoptosis evaluated by
flow cytometry. Cell Biol. Int. 31, 269-278.
Opitz, C. A., Leake, M. C., Makarenko, I., Benes, V. and Linke, W. A. (2004).
Developmentally regulated switching of titin size alters myofibrillar stiffness in the
perinatal heart. Circ. Res. 94, 967-975.
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’antoni, M. L., Debuque, R.,
Chandran, A., Wang, L., Arora, K., Rosenthal, N. A. et al. (2016). Revisiting
cardiac cellular composition. Circ. Res. 118, 400-409.
Polizzotti, B. D., Ganapathy, B., Walsh, S., Choudhury, S., Ammanamanchi, N.,
Bennett, D. G., Dos Remedios, C. G., Haubner, B. J., Penninger, J. M. and
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